EULAC-PerMed and EU-LAC ResInfra both focus on building EU-CELAC cooperation frameworks in health and research infrastructure.
AGENCIA NACIONAL DE INVESTIGACION Y DESARROLLO
Chile's national research funding agency bridging EU and Latin American research cooperation in health, raw materials, and infrastructure.
Their core work
ANID is Chile's national research and development funding agency, responsible for coordinating and financing the country's public research programs. In H2020, they serve as the Chilean government's bridge to European research cooperation, participating in coordination actions that align EU and Latin American (CELAC) research agendas. Their role is not to perform research but to co-fund programs, harmonize research priorities across continents, and facilitate access for Chilean researchers to European infrastructure and vice versa.
What they specialise in
All three projects (ERA-MIN 2, EULAC-PerMed, EU-LAC ResInfra) involve coordinating funding programs across national boundaries.
ERA-MIN 2 coordinated research programs on raw materials, recycling, and substitution of critical raw materials.
EULAC-PerMed widened EU-CELAC cooperation specifically in personalized medicine, omics, and prevention.
How they've shifted over time
ANID's early H2020 involvement (2016) focused on raw materials and circular economy through ERA-NET coordination, reflecting Chile's strategic interest in mining and mineral resources. By 2019, their focus shifted decisively toward health research (personalized medicine) and research infrastructure cooperation under the EU-CELAC political framework. This evolution shows a broadening from sector-specific resource coordination toward wider science diplomacy and institutional research cooperation.
ANID is moving toward broader science diplomacy roles, positioning Chile as a key Latin American partner for European research infrastructure access and health research co-programming.
How they like to work
ANID exclusively participates as a partner, never as coordinator — consistent with its role as a national funding body joining multilateral coordination actions rather than leading technical research. With 46 unique partners across 24 countries from just 3 projects, they operate in very large consortia typical of CSA and ERA-NET schemes. This makes them a gateway organization: partnering with ANID provides access to Chilean research funding and the broader Latin American research community.
Despite only 3 projects, ANID connects to 46 partners across 24 countries, reflecting participation in large-scale coordination actions that span both European and Latin American research systems. Their network is exceptionally broad geographically, functioning as a bridge between EU and CELAC research communities.
What sets them apart
ANID is one of the few Latin American national funding agencies actively embedded in H2020 coordination actions, making them a rare non-European government partner. For any consortium seeking EU-Latin America cooperation or access to Chilean research funding streams, ANID is the institutional entry point. Their value is not technical expertise but political and funding infrastructure across the EU-CELAC axis.
Highlights from their portfolio
- EU-LAC ResInfraLargest funding share (EUR 105,250) and directly addresses EU-CELAC research infrastructure access — a strategic political priority for both regions.
- EULAC-PerMedDemonstrates ANID's expansion beyond natural resources into health, specifically widening personalized medicine cooperation between EU and Latin America.